Inter_Co_new_brand_1_png.png
Inter&Co Inc. Reports Record Profit in Q2, Advances 60/30/30 Plan
August 07, 2024 07:19 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading financial super app providing financial and digital commerce services to over 33...
barinthuslogo.jpg
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
June 12, 2024 16:01 ET | Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
Azuria_WS_RGB_pos (1).png
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
June 11, 2024 10:36 ET | Azuria Water Solutions
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET | AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
Inter_Co_new_brand_1_png.png
Moody's assigns debut AA+.br ratings to Inter, recognizing strong financial position
May 31, 2024 10:16 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, May 31, 2024 (GLOBE NEWSWIRE) -- Inter&Co (NASDAQ: INTR), the leading financial super app serving over 32 million customers across the Americas, is pleased to announce...
Inter_Co_new_brand_1_png.png
Inter&Co doubles down on SMEs through acquisition of Granito
May 28, 2024 07:33 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, May 28, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), announces that Banco Inter S.A. entered into a share purchase agreement to acquire the...
Mural_Logo.jpg
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024 17:00 ET | Mural Oncology, Inc.
ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic proof of mechanism in ARTISTRY-3...
Inter_Co_new_brand_1_png.png
S&P reviews Banco Inter's outlook to Stable and reaffirms its "brAA+" rating
May 20, 2024 19:15 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, May 20, 2024 (GLOBE NEWSWIRE) -- Inter&Co (NASDAQ: INTR), the financial super app serving over 32 million customers across the Americas, announced today that S&P...
Mural_Logo.jpg
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024 07:00 ET | Mural Oncology, Inc.
Mural Oncology reiterates cash runway projection into 4Q 2025, with sufficient capital to fund key clinical readouts.
Inter_Co_new_brand_1_png.png
Inter&Co Inc. Reports Record Profit
May 09, 2024 09:01 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, May 09, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the premier financial super app that provides financial and digital commerce services to over...